toxylact: a06ag07 sorbitol

The first professional lActological database in the word

Sorbitol enemas (ATC A06AG07) are osmotic laxatives used for short‑term relief of constipation and pre‑procedural bowel cleansing; available lactation data and pharmacokinetics suggest very low risk to breastfed infants when used appropriately, though high maternal oral exposure has shown adverse effects in animal models and warrants caution.pubmed.ncbi.nlm.nih+4

Pharmacological profile

Sorbitol is a polyhydric sugar alcohol naturally present in various fruits and widely used as an osmotic laxative in oral solutions and rectal enemas.clevelandclinic+2
Rectal sorbitol solutions increase intraluminal osmotic pressure, attract water into the colonic lumen, soften stool, and stimulate peristalsis, producing bowel movements typically within minutes to about an hour.rxlist+2
ATC class A06AG07 includes sorbitol preparations indicated as cleansing enemas for constipation and for bowel emptying prior to diagnostic or surgical interventions on the large intestine.rxlist+1

Therapeutic indications and use

Sorbitol enemas are used in adults and older children for acute constipation, including pre‑operative and pre‑procedural bowel preparation when a rapid, localized laxative effect is desired.clevelandclinic+2
They are generally considered second‑line, short‑course treatments after non‑pharmacological measures and oral osmotic or bulk‑forming laxatives, especially in breastfeeding women.fpnotebook+1
Standard enema dosage (for typical commercial solutions) involves administration of a single rectal dose of a 25–30% sorbitol solution, often around 120 mL, as needed or according to medical prescription.dailymed.nlm.nih+1

General toxicity and adverse effects

Sorbitol acts primarily within the intestinal lumen and exhibits minimal systemic absorption when used rectally, which limits systemic toxicity under recommended dosing.rxlist+1
Common adverse effects include abdominal cramping, flatulence, diarrhea, rectal discomfort, and, with excessive or repeated dosing, risk of fluid and electrolyte disturbances such as dehydration.webmd+2
Overdose or chronic high oral intake may cause significant gastrointestinal irritation and metabolic disturbances, and poisoning requires prompt medical assessment and supportive care.webmd+1

Experimental animal data indicate that high oral maternal sorbitol exposure during lactation can induce metabolic alterations, hepatocyte genotoxicity, and myelotoxicity in offspring, in a dose‑dependent manner.pubmed.ncbi.nlm.nih
These findings derive from doses far above typical human dietary or medicinal exposure but support a precautionary approach to prolonged high‑dose use in breastfeeding women.pubmed.ncbi.nlm.nih+1

Lactation‑toxicology considerations

Available human lactation resources classify medicinal sorbitol as compatible with breastfeeding, with low risk expected due to poor oral absorption and negligible passage into breast milk after usual doses.fpnotebook+2
For rectal enemas, systemic bioavailability is limited, and any sorbitol that might reach breast milk is expected to be minimal and unlikely to cause osmotic effects in the infant’s gut.clevelandclinic+2
Major reference centers emphasize that most medications, including many laxatives, can be used during breastfeeding, particularly when infant risk is low and maternal benefit is clear.drugs+2

Given the animal data showing genotoxic and myelotoxic changes after high maternal intake, prolonged high‑dose oral sorbitol ingestion (e.g., large volumes of concentrated solution as daily therapy) should be avoided during lactation when alternatives exist.pubmed.ncbi.nlm.nih+1
Single or short‑course rectal sorbitol enemas for acute constipation in a healthy lactating woman, using standard doses and under medical supervision, are unlikely to require interruption of breastfeeding or special measures for the infant.journals.sagepub+2

Clinical recommendations in breastfeeding

Non‑pharmacological strategies (hydration, increased dietary fiber, physical activity) and safer oral osmotic or bulk‑forming laxatives should be considered first‑line for constipation in breastfeeding women.fpnotebook+1
When a rapid local effect is clinically necessary, a single sorbitol enema can be used with attention to dose, avoidance of repeated unsupervised use, and monitoring for maternal diarrhea and dehydration.dailymed.nlm.nih+2
No routine “pump‑and‑dump” or temporary cessation of breastfeeding is recommended for standard‑dose sorbitol enemas; instead, clinicians should individualize therapy based on infant prematurity, comorbidities, and overall maternal medication burden.fpnotebook+2

Healthcare professionals should avoid prescribing chronic high‑dose sorbitol regimens in lactating women and should reassess underlying causes of constipation, including diet, other medications (especially opioids), and pelvic floor dysfunction.pubmed.ncbi.nlm.nih+2
Counseling should include discussion of expected laxative onset, potential transient gastrointestinal discomfort, and clear guidance to seek medical advice if there is rectal bleeding, persistent abdominal pain, or lack of response.webmd+2

Contraindications and precautions

Sorbitol enemas are contraindicated in patients with known hypersensitivity to sorbitol or formulation excipients, and in those with active gastrointestinal bleeding.rxlist+1
Additional precautions include avoiding use in suspected bowel obstruction, acute surgical abdomen, severe inflammatory bowel disease, or significant renal or cardiac impairment where fluid shifts may be poorly tolerated.clevelandclinic+1
In breastfeeding women with premature or medically fragile infants, clinicians may prefer alternative laxatives with more robust safety data, although occasional rectal sorbitol use still appears to pose very low direct risk to the infant.fpnotebook+2

Practical lactation‑toxicology summary

From a lactation‑toxicology standpoint, rectal sorbitol (A06AG07) exhibits favorable characteristics: localized action, poor systemic absorption, and minimal expected transfer into human milk.clevelandclinic+2
Human reference databases classify sorbitol as compatible or low risk in breastfeeding, while animal studies at extreme doses highlight potential long‑term toxicity, reinforcing the principle of lowest effective dose and shortest possible duration.pubmed.ncbi.nlm.nih+2
For lactation‑focused web monographs, sorbitol enemas can be presented as acceptable short‑course options in breastfeeding, with a clear preference for non‑pharmacological and oral agents first, and with explicit caution against chronic high‑dose exposure.drugs+2

Recent ARTICLES

July 24

Abdominal Compartment Syndrome

PWhile the formal term and its consensus definitions were codified by the World Society of the Abdominal Compartment Syndrome (WSACS) only in the early 2000s, the physiological underpinnings have been observed for over 150 years. In 1863, the French physiologist Etienne-Jules Marey was the first to document the reciprocal relationship between intra-abdominal pressure (IAP) and respiratory function, noting that the expansion of the abdominal cavity directly impacted the efficiency of the thoracic bellows.

July 18

Assessment of Postoperative Fever

For the physician and the student of medicine, the assessment of postoperative fever is not merely a task of temperature monitoring, but a diagnostic journey that requires a nuanced understanding of immunology, physiology, and clinical timing. Guided by the principle of "Primum non nocere," this report seeks to bridge the gap between complex pathophysiological mechanisms and the empathetic care of the patient, providing a comprehensive framework for identifying, understanding, and managing this common clinical challenge.

July 14

Clinical Review of Congenital and Acquired Cystic Kidney Diseases

The healing arts, as envisioned by the ancient traditions of medicine, seek not merely the eradication of pathology but the restoration of a delicate equilibrium between the body’s internal environment and the external world. In the realm of nephrology, cystic diseases of the kidney represent a profound disruption of this balance.

Spotlight

A Comprehensive Analysis of Complement System Deficiencies in Pediatric and Adult Populations

The human immune system is a tapestry of ancient evolutionary mechanisms and highly specialized adaptive responses, woven together to maintain the delicate equilibrium of health. At the heart of this architecture lies the complement system, a complex network of over fifty proteins that function as the primordial vanguard of innate immunity. Named for its ability to "complement" the action of antibodies, this system serves as a bridge between the immediate, non-specific recognition of pathogens and the targeted, long-term memory of the adaptive immune response. However, when this sentinel falls silent due to genetic or acquired deficiencies, the result is a state of nuanced immunosuppression that significantly alters the human clinical landscape across all ages.